Advertisement

Early Changes in Regional Cerebral Metabolic Rates for Glucose and Oxygen and in Regional Cerebral Blood Flow of Malignant Gliomas After Intraarterial Chemotherapy with ACNU: Positron Emission Tomography Studies in 14 Patients

  • N. Roosen
  • K.-J. Langen
  • T. Kuwert
  • J. C. W. Kiwit
  • T. Kahn
  • H. Herzog
  • E. Rota
  • W. J. Bock
  • L. E. Feinendegen
Conference paper

Abstract

The prognosis of malignant gliomas remains grave despite surgery, radiotherapy and various kinds of adjuvant therapy, including chemotherapy. At our institution these tumors are treated with a combination of postoperative radiotherapy and intra-arterial (i.a.) chemotherapy with ACNU (iaACNU) as is reported elsewhere in the Proceedings of the XVth Congress of the European Society of Neuroradiology, Würzburg 1988. Because only some of these neoplasms respond to chemotherapy, a number of patients are treated unnecessarily with i.a. chemotherapy, which may have serious side effects. The measurement of early metabolic effects of iaACNU may provide important information to distinguish responders from non-responders. Previously published reports concerning the metabolic effects of chemotherapy in malignant gliomas dealt with longterm changes observed after completion of chemotherapy or after at least several cycles of radiochemotherapy. The present study reports on early effects of iaACNU in patients with malignant gliomas as mea sured with the use of positron emission tomography (PET).

Keywords

Posi Tron Emission Tomography Malignant Glioma Posi Tron Emission Tomography Study Regional Cerebral Blood Flow Intraarterial Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brooks DO, Beaney RP, Thomas DGT (1986) The role of positron emission tomography in the study of cerebral tumors. Semin Oncol 13:83–93PubMedGoogle Scholar
  2. Derlonj M, Bourdet C, Chatel M, et al (1987) Study of 11 C-L-methionine uptake in brain gliomas by positron emission tomography: metabolic grading, and effects of radiotherapy and intra-arterial chemotherapy. In: Chatel M, Darcel F, Pecker S (eds) Brain oncology. Biology, diagnosis and therapy, pp 179–184-. Martinus Nijhoff Publ, Dordrecht, BostonCrossRefGoogle Scholar
  3. Di Chiro G, Brooks RA, Patronas N3, et al (1984) Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 15 (Suppl): S138-S14-6CrossRefGoogle Scholar
  4. Di Chiro G, De La Paz RL, Brooks RA, et al (.1982 ) Glucose utilization of cerebral gliomas measured by [18 F]fluorodeoxyglucose and positron emission tomography. Neurology 32:1323–1329PubMedCrossRefGoogle Scholar
  5. Frackowiak RS3, Lenzi GL, Jones T, Heather 3D (1980) Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 150 and positron emisssion tomography: theory, procedure, and normal values. 3 Comput Assist Tomogr 4:727–736CrossRefGoogle Scholar
  6. Hawkins RA, Phelps ME, Huang SC (1986) Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. 3 Cereb Blood Flow Metab 6:170–183CrossRefGoogle Scholar
  7. Hori T, Muraoka K, Saito Y, et al (1987) Influence of modes of ACNU administration on tissue and blood concentration in malignant brain tumors. 3 Neurosurg 66:372–378CrossRefGoogle Scholar
  8. Kohn KW, Erickson LC, Laurent G, et al (1981) DNA crosslinking and the origin of sensitivity to chloroethylnitrosureas. In: Prestayko AW, Baker LH, Crooke ST, et al (eds) Nitrosoureas. Current status and new developments, pp 69–83. Academic Press, New York, LondonGoogle Scholar
  9. Leenders KL, Thomas DGT, Beaney RP, Brooks D3 (1985) Cerebral gliomas studied with positron emission tomography. In: Voth D, Krauseneck P (eds) Chemotherapy of gliomas. Basic research, experiences and results, pp 101–109. Walter de Gruyter, Berlin, New YorkGoogle Scholar
  10. Mineura K, Yasuda T, Kowada M, et al (1987) Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocir-culation and metabolism in patients with gliomas. 3 Neuro-Oncol 5:277–285CrossRefGoogle Scholar
  11. Mori T, Mineura K, Katakura R (1979) A consideration on pharmacokinetics of a new water-soluble anti-tumor nitrosourea, ACNU, in patients with malignant brain tumor. No To Shinkei 31:601–606 (3pn)PubMedGoogle Scholar
  12. Patronas N3, Di Chiro G, Brooks RA, et al (1982) Work in progress: [18F]-Flu-orodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis in the brain. Radiology 144: 885–889PubMedGoogle Scholar
  13. Phelps ME, Huang SC, Hoffman EB, et al (1978) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371–388CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • N. Roosen
  • K.-J. Langen
  • T. Kuwert
  • J. C. W. Kiwit
  • T. Kahn
  • H. Herzog
  • E. Rota
  • W. J. Bock
  • L. E. Feinendegen

There are no affiliations available

Personalised recommendations